A5072728156- Malaria Research and Control
- Mosquito-borne diseases and control
- Travel-related health issues
- HIV Research and Treatment
- Pericarditis and Cardiac Tamponade
- Drug-Induced Hepatotoxicity and Protection
- HIV/AIDS drug development and treatment
- Hepatitis Viruses Studies and Epidemiology
- Global Maternal and Child Health
- Adrenal Hormones and Disorders
- HIV/AIDS Research and Interventions
- Myasthenia Gravis and Thymoma
University of Ibadan
2021-2023
University College Hospital, Ibadan
2021
Institute for Advanced Medical Research
2021
Abstract Background Although the global malaria burden is decreasing, there are still concerns about overdiagnosis of and danger misdiagnosis non-malaria causes fever. Clinicians continue to face challenge differentiating between these despite introduction rapid diagnostic tests (mRDTs). Aim To determine prevalence non-malaria-caused fever in children South-Western Nigeria. Methods Secondary analysis data obtained evaluate effect restricting antimalarial treatment positive mRDT rural urban...
Context and Aim: Given the challenges of microscopy, we compared its performance with SD-Bioline malaria rapid diagnostic test (MRDT) polymerase chain reaction (PCR) evaluated time it took for positive results to become negative after treatment children acute uncomplicated malaria. Subjects Methods: We present report 485 participants complete MRDT, PCR data out 511 febrile aged 3–59 months who participated in a cohort study over 12-month period rural urban areas Ibadan, Nigeria....
There are about 2.1 million children infected with HIV globally and 120,000 deaths annually. Nigeria has one of the highest rates pediatric infection globally. Pretreatment drug resistance data inform choice first- second-line antiretroviral therapy (ART) regimens. This study investigated prevalence drug-resistant strains among ART-naive in Ibadan, Nigeria. A total 20 aged <15 years were enrolled. Demographic, clinical, laboratory documented. Total nucleic acid was extracted from blood...
Abstract Background: Declining responsiveness to artemether-lumefantrine (AL), the ACT of choice since 2005, has been reported in Nigeria. Pyronaridine-artesunate (PA) is a newer fixed-dose recently included WHO list prequalified medicines for treatment uncomplicated falciparum malaria. However, data from Nigerian paediatric population scarce. Therefore, we compared efficacy and safety pyronaridine-artesunate with using 28-day antimalarial protocol Ibadan, southwest Method: In an...